Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yongxing Gong

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Cell Cycle (Georgetown, Tex.)|December 9, 2014
Molecular mechanisms orchestrating cyclin stabilityYongxing Gong, Timothy A Chan
Neoplasia (New York, N.Y.)|December 31, 2016
Pan-Cancer Analysis Links PARK2 to BCL-XL-Dependent Control of ApoptosisYongxing Gong, Steven E Schumacher, Wei H Wu, et al.
Microbiology (Reading, England)|July 18, 2009
Global transcriptional analysis of acid-inducible genes in Streptococcus mutans: multiple two-component systems involved in acid adaptationYongxing Gong, Xiao-Lin Tian, Tara Sutherland, et al.
Science Advances|June 5, 2020
Targeting therapeutic vulnerabilities with PARP inhibition and radiation in IDH-mutant gliomas and cholangiocarcinomasYuxiang Wang, Aaron T Wild, Sevin Turcan, et al.
Molecular Cancer Therapeutics|November 18, 2021
Targeting the mTOR Pathway in Hurthle Cell Carcinoma Results in Potent Antitumor ActivityYiyu Dong, Yongxing Gong, Fengshen Kuo, et al.
Nature Genetics|May 6, 2014
Pan-cancer genetic analysis identifies PARK2 as a master regulator of G1/S cyclinsYongxing Gong, Travis Ian Zack, Luc G T Morris, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 9, 2011
Genomic dissection of the epidermal growth factor receptor (EGFR)/PI3K pathway reveals frequent deletion of the EGFR phosphatase PTPRS in head and neck cancersLuc G T Morris, Barry S Taylor, Trever G Bivona, et al.
Biorxiv : the Preprint Server for Biology|April 10, 2026
Neural cell state modulation by <i>PARK2</i> and dopaminergic neuroprotection by small molecule Parkin agonismYongxing Gong, Armin Bayati, Tyler J Alban, et al.
Science Advances|June 22, 2022
Mitonuclear genotype remodels the metabolic and microenvironmental landscape of Hürthle cell carcinomaIan Ganly, Eric Minwei Liu, Fengshen Kuo, et al.
Nature Genetics|January 29, 2013
Recurrent somatic mutation of FAT1 in multiple human cancers leads to aberrant Wnt activationLuc G T Morris, Andrew M Kaufman, Yongxing Gong, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Cell Cycle (Georgetown, Tex.)|December 9, 2014
Molecular mechanisms orchestrating cyclin stabilityYongxing Gong, Timothy A Chan
Neoplasia (New York, N.Y.)|December 31, 2016
Pan-Cancer Analysis Links PARK2 to BCL-XL-Dependent Control of ApoptosisYongxing Gong, Steven E Schumacher, Wei H Wu, et al.
Microbiology (Reading, England)|July 18, 2009
Global transcriptional analysis of acid-inducible genes in Streptococcus mutans: multiple two-component systems involved in acid adaptationYongxing Gong, Xiao-Lin Tian, Tara Sutherland, et al.
Science Advances|June 5, 2020
Targeting therapeutic vulnerabilities with PARP inhibition and radiation in IDH-mutant gliomas and cholangiocarcinomasYuxiang Wang, Aaron T Wild, Sevin Turcan, et al.
Molecular Cancer Therapeutics|November 18, 2021
Targeting the mTOR Pathway in Hurthle Cell Carcinoma Results in Potent Antitumor ActivityYiyu Dong, Yongxing Gong, Fengshen Kuo, et al.
Nature Genetics|May 6, 2014
Pan-cancer genetic analysis identifies PARK2 as a master regulator of G1/S cyclinsYongxing Gong, Travis Ian Zack, Luc G T Morris, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 9, 2011
Genomic dissection of the epidermal growth factor receptor (EGFR)/PI3K pathway reveals frequent deletion of the EGFR phosphatase PTPRS in head and neck cancersLuc G T Morris, Barry S Taylor, Trever G Bivona, et al.
Biorxiv : the Preprint Server for Biology|April 10, 2026
Neural cell state modulation by <i>PARK2</i> and dopaminergic neuroprotection by small molecule Parkin agonismYongxing Gong, Armin Bayati, Tyler J Alban, et al.
Science Advances|June 22, 2022
Mitonuclear genotype remodels the metabolic and microenvironmental landscape of Hürthle cell carcinomaIan Ganly, Eric Minwei Liu, Fengshen Kuo, et al.
Nature Genetics|January 29, 2013
Recurrent somatic mutation of FAT1 in multiple human cancers leads to aberrant Wnt activationLuc G T Morris, Andrew M Kaufman, Yongxing Gong, et al.
Pageof 2